| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |